The work of the RDI is at the cutting edge of the emerging field of pharmacogenomics - tailoring drug therapy for the individual patient on the basis of genetic information. In addition, the formation of a network of scientists and physicians and a not-for-profit organization around the principles of free sharing of data and free access to the services is a new paradigm.
Listed below are press releases from the RDI, some examples of news
coverage and back issues of RDI e-News, our electronic newsletter. To
subscribe to RDI e-News register here.
Bristol-Myers Squibb joins RDI in combating HIV drug resistance (Thursday April 7, 2005)
Artificial intelligence identifies effective drugs for HIV patients
whose treatment is failing (Thursday June 12, 2003)
RDI receives major funding and data from
leading HIV centre (Tuesday April 29, 2003)
New not-for-profit organization launched
to combat HIV resistance (Tuesday March 4,2003)
Global initiative launched to combat HIV
drug resistance (Thursday July 4, 2002)
Database to Track HIV Drug Resistance
http://www.healthdatamanagement.com/html/news/NewsStory.cfm?DID=8779
Pooled database aims to improve management of drug-resistant HIV
infection
http://www.aidsmeds.com/news/20020704clin024.html
To
subscribe to RDI e-News please register on our home page.
To obtain Adobe Acrobat Reader click here:
